Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-839-0 | CAS number: 381-73-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- publication
- Title:
- Tissue distribution, excretion, and urinary metabolites of dichloroacetic acid in the male Fischer 344 rat
- Author:
- Lin EL, Mattox JK, Daniel FB.
- Year:
- 1 993
- Bibliographic source:
- J Toxicol Environ Health. 1993 Jan;38(1):19-32
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other:
- Principles of method if other than guideline:
- The disposition of dichloroacetic acid (DCA) was investigated in Fischer 344 rats over the 48 hr after oral gavage of 282 mg/kg of 1- or 2-(14C)-DCA (1-DCA or 2-DCA) and 28.2 mg/kg of 2-DCA
- GLP compliance:
- no
Test material
- Reference substance name:
- Dichloroacetic acid
- EC Number:
- 201-207-0
- EC Name:
- Dichloroacetic acid
- Cas Number:
- 79-43-6
- IUPAC Name:
- dichloroacetic acid
- Reference substance name:
- dichloroacetic acid (DCA)
- IUPAC Name:
- dichloroacetic acid (DCA)
- Test material form:
- other: Liquid
- Details on test material:
- - Name of test material (as cited in study report): (14C)-DCA
- Molecular formula (if other than submission substance): C2H2Cl2O2
- Molecular weight (if other than submission substance): 128.94 g/mol
- Substance type: Organic
- Physical state: Liquid
- Impurities (identity and concentrations): NA
Constituent 1
Constituent 2
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- not specified
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on exposure:
- The disposition of dichloroacetic acid (DCA) was investigated in Fischer 344 rats over the 48 hr after oral gavage of 282 mg/kg of 1- or 2-(14C)-DCA (1-DCA or 2-DCA) and 28.2 mg/kg of 2-DCA.
- Duration and frequency of treatment / exposure:
- 48 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
282 mg/kg of 1- or 2-(14C)-DCA (1-DCA or 2-DCA) and 28.2 mg/kg of 2-DCA
- No. of animals per sex per dose / concentration:
- Details not available
- Control animals:
- not specified
Results and discussion
Main ADME resultsopen allclose all
- Type:
- absorption
- Results:
- DCA was absorbed quickly
- Type:
- distribution
- Results:
- The major route of disposition was through exhalation of carbon dioxide and elimination in the urine.
- Type:
- metabolism
- Results:
- The primary metabolic pathway for dichloroacetic acid (DCA) involves oxidative dechlorination to form glyoxylate.
- Type:
- excretion
- Results:
- Excretion of dichloroacetic acid was through exhalation of carbon dioxide and elimination in the urine
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Absorption: DCA was absorbed quickly
- Details on distribution in tissues:
- Distribution: The major route of disposition was through exhalation of carbon dioxide and elimination in the urine. After 48 hr, 36.4%, 26.2%, and 20.8% of the dose was retained in the tissues of rats administered 28.2 and 282 mg/kg of 2-DCA and 282 mg/kg of 1-DCA, respectively.
- Details on excretion:
- Excretion: Excretion of dichloroacetic acid was through exhalation of carbon dioxide and elimination in the urine.
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- glycolic acid
glyoxylic acid and
oxalic acid
The metabolic pathway is presented as a figure below (Source: Toxicological review of Dichloroacetic acid, in support of Summary Information in the Integrated Risk Information System (IRIS), August 2003, USEPA)
Any other information on results incl. tables
Metabolism: The primary metabolic pathway for dichloroacetic acid (DCA) involves oxidative dechlorination to form glyoxylate. The major urinary metabolites were glycolic acid, glyoxylic acid, and oxalic acid. DCA and its metabolites accumulated in the tissues and were eliminated slowly.
Organs exhibiting radioactivity: Liver
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): high bioaccumulation potential based on study results
Disposition is often used to describe the time-course of movement of chemicals through the body. In the present study, after 48 hr, 36.4%, 26.2%, and 20.8% of the dose was retained in the tissues of rats administered 28.2 and 282 mg/kg of 2-DCA and 282 mg/kg of 1-DCA, respectively. Also, DCA and its metabolites accumulated in the tissues and were eliminated slowly. This suggest high bio-accumulation potential of dichloroacetic acid (DCA) based on study results - Executive summary:
Disposition is often used to describe the time-course of movement of chemicals through the body. In the present study, after 48 hr, 36.4%, 26.2%, and 20.8% of the dose was retained in the tissues of rats administered 28.2 and 282 mg/kg of 2-DCA and 282 mg/kg of 1-DCA, respectively. Also, DCA and its metabolites accumulated in the tissues and were eliminated slowly. This suggest high bio-accumulation potential of dichloroacetic acid (DCA) based on study results
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.